Sezen Atasoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sezen Atasoy has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Aydan Dag
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, 34093, Istanbul, Turkey
9 shared publications - Pinar Sinem Omurtag Ozgen
Department of Analytical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
3 shared publications - Ayhan Devi̇ren
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Medical Biology, İstanbul, Turkey
2 shared publications - Belma Zengin Kurt
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Turkey
2 shared publications - Beyza Goncu
Department of Medical Services and Techniques, Vocational School of Health Services, Bezmialem Vakif University, Istanbul, Turkey
2 shared publications - Gulsah Yigit Erdem
Department of Biotechnology, Institute of Health Sciences, Bezmialem Vakif University, 34093, Istanbul, Turkey
2 shared publications
Latest Publications
- Open Access
- 11 March 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (7) , 3490-3505
A Biomimetic Nanoplatform for Near-Infrared-Assisted Heat-Mediated Synergistic Therapy for Glioblastoma
Cell membrane (CM) camouflage has emerged as a powerful biomimetic strategy for enhancing the precision of targeted drug delivery, offering an effective solution to the major limitations of phototheranostic nanomaterials, which often suffer from reduced therapeutic efficacy and imaging performance due to tumor heterogeneity and microenvironmental delivery barriers. Here, we report a biomimetic phototheranostic nanoplatform engineered for the synergistic treatment of glioblastoma multiforme (GBM) via near-infrared (NIR)-assisted, heat-enhanced chemotherapy. Magnetic nanoparticles (M) with improved stability and biocompatibility were synthesized to enable efficient magnetic hyperthermia. These nanoparticles were further functionalized with cancer CM and temozolomide (TMZ)-conjugated, cell-penetrating peptide-based copolymers (P), providing homotypic targeting capability and enhanced intratumoral accumulation. This multifunctional coating significantly improved selectivity toward GBM cells and enabled combined photothermal and chemotherapeutic activity. Cellular studies under both illuminated and dark conditions revealed pronounced synergistic cytotoxicity arising from the integration of NIR-mediated magnetic hyperthermia with TMZ delivery. Compared to nonpolymer-functionalized controls, the proposed system more effectively overcame tumor heterogeneity and microenvironmental barriers, yielding superior therapeutic performance. These findings highlight the potential of this biomimetic platform for targeted and multimodal GBM theranostics. Overall, this work introduces a versatile biomimetic nanocamouflage strategy that leverages natural cellular functionalities and nanotechnology to advance targeted GBM therapy, providing a promising avenue for more precise and effective treatment of highly malignant brain tumors.
- 11 March 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (7) , 3490-3505
Open AccessA Biomimetic Nanoplatform for Near-Infrared-Assisted Heat-Mediated Synergistic Therapy for Glioblastoma
Cell membrane (CM) camouflage has emerged as a powerful biomimetic strategy for enhancing the precision of targeted drug delivery, offering an effective solution to the major limitations of phototheranostic nanomaterials, which often suffer from reduced therapeutic efficacy and imaging performance due to tumor heterogeneity and microenvironmental delivery barriers. Here, we report a biomimetic phototheranostic nanoplatform engineered for the synergistic treatment of glioblastoma multiforme (GBM) via near-infrared (NIR)-assisted, heat-enhanced chemotherapy. Magnetic nanoparticles (M) with improved stability and biocompatibility were synthesized to enable efficient magnetic hyperthermia. These nanoparticles were further functionalized with cancer CM and temozolomide (TMZ)-conjugated, cell-penetrating peptide-based copolymers (P), providing homotypic targeting capability and enhanced intratumoral accumulation. This multifunctional coating significantly improved selectivity toward GBM cells and enabled combined photothermal and chemotherapeutic activity. Cellular studies under both illuminated and dark conditions revealed pronounced synergistic cytotoxicity arising from the integration of NIR-mediated magnetic hyperthermia with TMZ delivery. Compared to nonpolymer-functionalized controls, the proposed system more effectively overcame tumor heterogeneity and microenvironmental barriers, yielding superior therapeutic performance. These findings highlight the potential of this biomimetic platform for targeted and multimodal GBM theranostics. Overall, this work introduces a versatile biomimetic nanocamouflage strategy that leverages natural cellular functionalities and nanotechnology to advance targeted GBM therapy, providing a promising avenue for more precise and effective treatment of highly malignant brain tumors.
- 31 December 2025
- Published by Bor Dergisi in Journal of Boron
- Vol. 10 (4) , 140-149
Investigating the anticancer potential of boric acid against human gastric adenocarcinoma cells
Gastric cancer is a major contributor to cancer-related mortality worldwide, and the search for effective, targeted, and biocompatible therapeutic agents remains ongoing. Boric acid, a biologically active and low toxicity boron compound, has recently gained attention for its potential anticancer properties. This study aimed to investigate cytotoxic and proapoptotic effects of boric acid on human gastric adenocarcinoma cells (AGS) in vitro. The cell viability was assessed using a cytotoxicity assay following 24 h boric acid treatment, the IC50 value for AGS cells can be confidently stated as
- 31 December 2025
- Published by Bor Dergisi in Journal of Boron
- Vol. 10 (4) , 140-149
Investigating the anticancer potential of boric acid against human gastric adenocarcinoma cells
Gastric cancer is a major contributor to cancer-related mortality worldwide, and the search for effective, targeted, and biocompatible therapeutic agents remains ongoing. Boric acid, a biologically active and low toxicity boron compound, has recently gained attention for its potential anticancer properties. This study aimed to investigate cytotoxic and proapoptotic effects of boric acid on human gastric adenocarcinoma cells (AGS) in vitro. The cell viability was assessed using a cytotoxicity assay following 24 h boric acid treatment, the IC50 value for AGS cells can be confidently stated as
- 22 October 2025
- Published by Taylor & Francis in Journal of Macromolecular Science, Part A
- Vol. 62 (12) , 1238-1250
Bone-targeted stimuli-responsive polymeric nanocarriers for osteosarcoma treatment
- 22 October 2025
- Published by Taylor & Francis in Journal of Macromolecular Science, Part A
- Vol. 62 (12) , 1238-1250
Bone-targeted stimuli-responsive polymeric nanocarriers for osteosarcoma treatment
- 13 January 2025
- Published by Elsevier in European Polymer Journal
- Vol. 226
Remote-controlled release of therapeutics from multifunctional glycoplexes inhibit melanoma cells
- 13 January 2025
- Published by Elsevier in European Polymer Journal
- Vol. 226
Remote-controlled release of therapeutics from multifunctional glycoplexes inhibit melanoma cells
- 24 December 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (6) , 2150-2166
Multifunctional theranostic glyconanoprobes for synergistic eradication of breast cancer
Theranostic agents hold great promise for personalized medicine by combining diagnostic and therapeutic functions. Herein, two novel multifunctional theranostic glyconanoprobes targeting breast cancer were engineered for synergistic dual chemo-gene therapy and triple chemo-gene-photothermal therapy. Upconversion nanoparticles (UCNPs) were prepared and coated with a Dox-loaded glycopeptide polymer (P-Dox) to form UCNP@P-Dox for improving stability. UCNP@MP-Dox equipped for triple therapy was prepared by combining UCNP@P-Dox with magnetic (Fe3O4, M) nanoparticles with photothermal properties. To regulate the expression of the anti-apoptotic Bcl-2 protein, both UCNP@P-Dox and UCNP@MP-Dox were loaded with anti-Bcl-2 siRNA. Impressive photothermal efficiency and good MRI contrast were demonstrated in preliminary evaluations. Moreover, the UCNP@P-Dox/siRNA nanoprobe for dual therapy was shown in preclinical studies to significantly increase anti-tumor efficacy. In vivo experiments in tumor-induced mice showed nanoprobe accumulation in tumors and enhanced antitumor efficacy with combinatorial therapy over Dox and siRNA alone. This study demonstrates the tumor-targeting capability of multifunctional theranostic glyconanoprobes, establishing chemo-gene synergy as a potent therapeutic strategy for breast cancer.
- 24 December 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (6) , 2150-2166
Multifunctional theranostic glyconanoprobes for synergistic eradication of breast cancer
Theranostic agents hold great promise for personalized medicine by combining diagnostic and therapeutic functions. Herein, two novel multifunctional theranostic glyconanoprobes targeting breast cancer were engineered for synergistic dual chemo-gene therapy and triple chemo-gene-photothermal therapy. Upconversion nanoparticles (UCNPs) were prepared and coated with a Dox-loaded glycopeptide polymer (P-Dox) to form UCNP@P-Dox for improving stability. UCNP@MP-Dox equipped for triple therapy was prepared by combining UCNP@P-Dox with magnetic (Fe3O4, M) nanoparticles with photothermal properties. To regulate the expression of the anti-apoptotic Bcl-2 protein, both UCNP@P-Dox and UCNP@MP-Dox were loaded with anti-Bcl-2 siRNA. Impressive photothermal efficiency and good MRI contrast were demonstrated in preliminary evaluations. Moreover, the UCNP@P-Dox/siRNA nanoprobe for dual therapy was shown in preclinical studies to significantly increase anti-tumor efficacy. In vivo experiments in tumor-induced mice showed nanoprobe accumulation in tumors and enhanced antitumor efficacy with combinatorial therapy over Dox and siRNA alone. This study demonstrates the tumor-targeting capability of multifunctional theranostic glyconanoprobes, establishing chemo-gene synergy as a potent therapeutic strategy for breast cancer.
- 14 September 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (10) , e202400915
LC–MS and GC‐MS Analyses on Green Algae Penicillus Capitatus: Cytotoxic, Antimicrobial and Anticholinesterase Activity Screening Enhanced by Molecular Docking & Dynamics and ADME Studies
In this comprehensive screening study, the chemical composition, and cytotoxic, antimicrobial, and anticholinergic activities of the green algae Penicillus capitatus, collected from Antalya‐Türkiye, were determined as in vitro and in silico. GC‐MS analysis of the hexane extract revealed a high content of fatty acids, with hexadecanoic acid constituting half of the total fatty acid content. LC‐HRMS analysis of the DCM:MeOH extract identified ascorbic acid as the most abundant compound, followed by (−)‐epigallocatechin and salicylic acid. The DCM:MeOH extract exhibited potent cytotoxicity against MDA‐MB‐231 and MCF7 breast cancer cell lines, outperforming doxorubicin with lower IC50 values and a higher selectivity index. Additionally, the extract demonstrated significant antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans, along with selective inhibition of acetylcholinesterase (hAChE) over butyrylcholinesterase (hBChE). Molecular docking and dynamics studies revealed that apigenin‐7‐O‐glucoside and epigallocatechin form stable interactions with estrogen receptor alpha (ERα) and hAChE, suggesting their potential as inhibitors. In silico ADME studies indicated favorable pharmacokinetic profiles for the detected compounds, supporting their potential as drug candidates. The promising cytotoxic activity of the P. capitatus extracts, coupled with significant antimicrobial properties and selective hAChE inhibition, highlights their therapeutic potential for breast cancer treatment, infection management, and neurodegenerative disease intervention.
- 14 September 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (10) , e202400915
LC–MS and GC‐MS Analyses on Green Algae Penicillus Capitatus: Cytotoxic, Antimicrobial and Anticholinesterase Activity Screening Enhanced by Molecular Docking & Dynamics and ADME Studies
In this comprehensive screening study, the chemical composition, and cytotoxic, antimicrobial, and anticholinergic activities of the green algae Penicillus capitatus, collected from Antalya‐Türkiye, were determined as in vitro and in silico. GC‐MS analysis of the hexane extract revealed a high content of fatty acids, with hexadecanoic acid constituting half of the total fatty acid content. LC‐HRMS analysis of the DCM:MeOH extract identified ascorbic acid as the most abundant compound, followed by (−)‐epigallocatechin and salicylic acid. The DCM:MeOH extract exhibited potent cytotoxicity against MDA‐MB‐231 and MCF7 breast cancer cell lines, outperforming doxorubicin with lower IC50 values and a higher selectivity index. Additionally, the extract demonstrated significant antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans, along with selective inhibition of acetylcholinesterase (hAChE) over butyrylcholinesterase (hBChE). Molecular docking and dynamics studies revealed that apigenin‐7‐O‐glucoside and epigallocatechin form stable interactions with estrogen receptor alpha (ERα) and hAChE, suggesting their potential as inhibitors. In silico ADME studies indicated favorable pharmacokinetic profiles for the detected compounds, supporting their potential as drug candidates. The promising cytotoxic activity of the P. capitatus extracts, coupled with significant antimicrobial properties and selective hAChE inhibition, highlights their therapeutic potential for breast cancer treatment, infection management, and neurodegenerative disease intervention.
- Open Access
- 5 January 2023
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 57 (5) , 237-242
The effects of prophylactic tadalafil use on VEGF expression in the rabbit model of steroid-induced femoral head avascular necrosis
Objective: The purpose of this study was to examine the effect of prophylactic tadalafil use on a steroid-induced femoral head avascular necrosis model in terms of microscopic, imaging, and molecular biological changes. Methods: Twenty-four New Zealand rabbits were divided into 3 equal groups. Eight rabbits were designated as the control group and did not receive treatment. Rabbits in group 1 (G1) received 0.1 mg/kg Escherichia coli lipopolysaccharide (LPS) intravenously and 40 mg/ kg methylprednisolone sodium succinate (MP) was administered intramuscularly for 3 days consecutively. Rabbits in group 2 (G2) were given 5 mg/kg tadalafil orally for 10 consecutive days. Starting on the eighth day, 0.1 mg/kg LPS was given, and following this 40 mg/kg MP injections were administered for 3 days. All animals were sacrificed 3 weeks after the final MP injection. Magnetic resonance imaging was performed, and bilateral femora were harvested. Half of the femoral head was stored for Vascular Endothelial Growth Factor (VEGF) examination with Western blot analysis. The other half was examined microscopically for the presence of osteonecrosis. Results: In G1, 15 out of 16 hips (93%) of the 8 rabbits had osteonecrosis compared to 8 out of 12 hips (67%) of 6 rabbits in G2 (P > .05). The VEGF expression in G2 was significantly higher than in the control group and G1 (P < .05 and P < .001, respectively). There was no significant difference in VEGF expression between the control group and G1 (P > .05). Conclusion: This study has shown us that femoral head osteonecrosis can be reliably induced with LPS and corticosteroid, as described in the literature. Prophylactic tadalafil use did not decrease the occurrence of osteonecrosis significantly. However, it significantly increased VEGF expression in the femoral head independent of the effects of steroids and LPS. Cite this article as: Özmen E, İzol Özmen H, Atasoy S, Dursun M, Bilgiç B, Salduz A. The effects of prophylactic tadalafil use on VEGF expression in the rabbit model of steroid-induced femoral head avascular necrosis. Acta Orthop Traumatol Turc., 2023;57(5):237-242.
- 5 January 2023
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 57 (5) , 237-242
Open AccessThe effects of prophylactic tadalafil use on VEGF expression in the rabbit model of steroid-induced femoral head avascular necrosis
Objective: The purpose of this study was to examine the effect of prophylactic tadalafil use on a steroid-induced femoral head avascular necrosis model in terms of microscopic, imaging, and molecular biological changes. Methods: Twenty-four New Zealand rabbits were divided into 3 equal groups. Eight rabbits were designated as the control group and did not receive treatment. Rabbits in group 1 (G1) received 0.1 mg/kg Escherichia coli lipopolysaccharide (LPS) intravenously and 40 mg/ kg methylprednisolone sodium succinate (MP) was administered intramuscularly for 3 days consecutively. Rabbits in group 2 (G2) were given 5 mg/kg tadalafil orally for 10 consecutive days. Starting on the eighth day, 0.1 mg/kg LPS was given, and following this 40 mg/kg MP injections were administered for 3 days. All animals were sacrificed 3 weeks after the final MP injection. Magnetic resonance imaging was performed, and bilateral femora were harvested. Half of the femoral head was stored for Vascular Endothelial Growth Factor (VEGF) examination with Western blot analysis. The other half was examined microscopically for the presence of osteonecrosis. Results: In G1, 15 out of 16 hips (93%) of the 8 rabbits had osteonecrosis compared to 8 out of 12 hips (67%) of 6 rabbits in G2 (P > .05). The VEGF expression in G2 was significantly higher than in the control group and G1 (P < .05 and P < .001, respectively). There was no significant difference in VEGF expression between the control group and G1 (P > .05). Conclusion: This study has shown us that femoral head osteonecrosis can be reliably induced with LPS and corticosteroid, as described in the literature. Prophylactic tadalafil use did not decrease the occurrence of osteonecrosis significantly. However, it significantly increased VEGF expression in the femoral head independent of the effects of steroids and LPS. Cite this article as: Özmen E, İzol Özmen H, Atasoy S, Dursun M, Bilgiç B, Salduz A. The effects of prophylactic tadalafil use on VEGF expression in the rabbit model of steroid-induced femoral head avascular necrosis. Acta Orthop Traumatol Turc., 2023;57(5):237-242.
- Open Access
- 29 June 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (3) , 370-375
A Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel
- 29 June 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (3) , 370-375
Open AccessA Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel
- Open Access
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 1764-1774
Investigating differential miRNA expression profiling using serum and urine specimens for detecting potential biomarkers for early prostate cancer diagnosis
Background/ Aim: MicroRNAs (miRNAs) are known up-to-date candidate biomarkers for several diseases. In addition obtaining miRNA from different body fluids such as serum, plasma, saliva, and urine is relatively easy to handle. Herein we aimed to detect miRNAs as biomarkers for early stage prostate cancer (PC). For this purpose, we used urine and serum samples to detect any significant differences in miRNA profiles between patients and healthy controls. Total ribonucleic acid (RNA) in urine and serum samples were isolated from eight untreated PC patients and thirty healthy individuals were screened for miRNA profile and candidate miRNAs were validated. Whole urinary and serum miRNA profile was analyzed using Affymetrix GeneChip miRNA 4.0 Arrays. Candidate miRNAs were investigated by stem-loop reverse transcription - polymerase chain reaction. According to our results, when analyzed urinary samples of PC patients 49 miRNAs were detected up-regulated and 14 miRNAs were found down-regulated when compared with healthy controls. According to the serum samples 19 miRNAs were found up-regulated and 21 miRNAs were found down-regulated when compared with healthy individuals as well. Interestingly we detected overlapped only four miRNAs (MIR320A, MIR4535, MIR4706, MIR6750) that commonly increase or decrease in both serum and urine samples. Among them MIR320A was found down-regulated, and MIR4535, MIR4706, MIR6750 were found up-regulated fo urine samples. However only MIR6750 was up-regulated and the other three miRNAs were down-regulated for serum samples. Notably, the expression profile of MIR320A was significantly altered in urine specimens of prostate cancer patients. We considered that MIR320A has been evaluated as a valuable biomarker that can be used in the early diagnosis of the PC.
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 1764-1774
Open AccessInvestigating differential miRNA expression profiling using serum and urine specimens for detecting potential biomarkers for early prostate cancer diagnosis
Background/ Aim: MicroRNAs (miRNAs) are known up-to-date candidate biomarkers for several diseases. In addition obtaining miRNA from different body fluids such as serum, plasma, saliva, and urine is relatively easy to handle. Herein we aimed to detect miRNAs as biomarkers for early stage prostate cancer (PC). For this purpose, we used urine and serum samples to detect any significant differences in miRNA profiles between patients and healthy controls. Total ribonucleic acid (RNA) in urine and serum samples were isolated from eight untreated PC patients and thirty healthy individuals were screened for miRNA profile and candidate miRNAs were validated. Whole urinary and serum miRNA profile was analyzed using Affymetrix GeneChip miRNA 4.0 Arrays. Candidate miRNAs were investigated by stem-loop reverse transcription - polymerase chain reaction. According to our results, when analyzed urinary samples of PC patients 49 miRNAs were detected up-regulated and 14 miRNAs were found down-regulated when compared with healthy controls. According to the serum samples 19 miRNAs were found up-regulated and 21 miRNAs were found down-regulated when compared with healthy individuals as well. Interestingly we detected overlapped only four miRNAs (MIR320A, MIR4535, MIR4706, MIR6750) that commonly increase or decrease in both serum and urine samples. Among them MIR320A was found down-regulated, and MIR4535, MIR4706, MIR6750 were found up-regulated fo urine samples. However only MIR6750 was up-regulated and the other three miRNAs were down-regulated for serum samples. Notably, the expression profile of MIR320A was significantly altered in urine specimens of prostate cancer patients. We considered that MIR320A has been evaluated as a valuable biomarker that can be used in the early diagnosis of the PC.
- 1 August 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 276, 114211
Evaluation of cytotoxic and antioxidant potential of Dittrichia viscosa (L.) Greuter used in traditional medicine
- 1 August 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 276, 114211
Evaluation of cytotoxic and antioxidant potential of Dittrichia viscosa (L.) Greuter used in traditional medicine